Chengdu (1)

Anti-PD-1 Antibody (1)

MSI-H (1)

Mmr Deficiency (1)

Radiotherapy (1)

Rectal Cancer (1)

Recruiting (1)

phase 1/phase 2 (1)

West China Hospital (1)

Chengdu Third People's Hospital (1)

First Affiliated Hospital of Chongqing Medical University (1)

Sichuan Cancer Hospital and Research Institute (1)

The Affiliated Hospital Of Southwest Medical University (1)

Yunnan Cancer Hospital (1)

hypofractionated radiotherapy (1)

sintilimab (1)

drug (1)

radiation (1)

Other (1)

Interventional (1)

mmr deficiency

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Apr 25, 2022